Planet 13 Holdings (PLNH) Interest Expenses (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Interest Expenses came in at $107.5 million in Q1 2026, up 5878.59% year-on-year from $1.8 million in Q1 2025, and up 2156.36% on a QoQ basis from -$5.2 million in Q4 2025.
Planet 13 Holdings (PLNH) Interest Expenses (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Interest Expenses data on file, last reported at $107.5 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 5878.59% year-over-year to $107.5 million in Q1 2026; TTM through Mar 2026 was $107.5 million, a 1808.67% increase from a year earlier, with the FY2025 full-year figure at $64.8 million, up 127.68% from the prior year.
- Interest Expenses for Q1 2026 stood at $107.5 million, up from -$5.2 million in the prior quarter.
- Over the last five years, Interest Expenses for PLNH reached as high as $107.5 million in Q1 2026 and fell as low as -$5.2 million in Q4 2025.
- Historically, Interest Expenses has averaged $30.2 million across 5 years, with a median of $8.5 million in 2024.
- Across the five-year window, Interest Expenses slumped 393.39% in 2025 and jumped 5878.59% in 2026, its largest moves.
- Year by year, Interest Expenses stood at $1.1 million in 2022, then slipped by 1.18% to $1.1 million in 2023, then surged by 67.71% to $1.8 million in 2024, then slumped by 393.39% to -$5.2 million in 2025, then surged by 2156.36% to $107.5 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $107.5 million in Q1 2026, -$5.2 million in Q4 2025, and $67.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | 107.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.50 Mn |
| Mar 31, 2026 | 107.50 Mn |
| Dec 31, 2025 | -5.23 Mn |
| Dec 31, 2025 | -5.23 Mn |
| Sep 30, 2025 | 67.00 Mn |
| Sep 30, 2025 | 67.00 Mn |
| Jun 30, 2025 | 8.17 Mn |
| Jun 30, 2025 | 8.17 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Jun 30, 2024 | 8.54 Mn |
| Jun 30, 2024 | 8.54 Mn |
| Mar 31, 2024 | 989,887.00 |
| Mar 31, 2024 | 989,887.00 |
| Dec 31, 2023 | 1.06 Mn |
| Dec 31, 2023 | 1.06 Mn |